These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 33390848)
1. NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway. Xu JC; Chen TY; Liao LT; Chen T; Li QL; Xu JX; Hu JW; Zhou PH; Zhang YQ Int J Biol Sci; 2021; 17(1):259-270. PubMed ID: 33390848 [TBL] [Abstract][Full Text] [Related]
2. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients. Liu JY; Jiang L; He T; Liu JJ; Fan JY; Xu XH; Tang B; Shi Y; Zhao YL; Qian F; Wang Y; Cui YH; Yu PW Cell Death Dis; 2019 Feb; 10(3):162. PubMed ID: 30770791 [TBL] [Abstract][Full Text] [Related]
3. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway. Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma. Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521 [TBL] [Abstract][Full Text] [Related]
6. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945 [TBL] [Abstract][Full Text] [Related]
7. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863 [TBL] [Abstract][Full Text] [Related]
8. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353 [TBL] [Abstract][Full Text] [Related]
9. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma. Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361 [TBL] [Abstract][Full Text] [Related]
10. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways. Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351 [TBL] [Abstract][Full Text] [Related]
11. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma. Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734 [TBL] [Abstract][Full Text] [Related]
12. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway. Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164 [TBL] [Abstract][Full Text] [Related]
14. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
15. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1. Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954 [TBL] [Abstract][Full Text] [Related]
16. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways. Zhang LN; Zhao L; Yan XL; Huang YH J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663 [TBL] [Abstract][Full Text] [Related]
17. Neuropilin and tolloid-like 2 regulates the progression of osteosarcoma. Wang X; Bian Z; Hou C; Li M; Jiang W; Zhu L Gene; 2021 Feb; 768():145292. PubMed ID: 33157203 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830 [TBL] [Abstract][Full Text] [Related]
19. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer. Zhang X; Liu S; Zhu Y Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]